Skip to main content
. 2012 Apr 3;12:83. doi: 10.1186/1471-2334-12-83

Figure 2.

Figure 2

Probabilistic sensitivity analysis (PSA); incremental cost-effectiveness ratio (ICER) of posaconazole versus SAT (standard azole treatment; fluconazole or itraconazole) in the prevention of invasive fungal infection (IFI) among high-risk neutropenic patients (ICER threshold considered is €30,000 per life-year saved).